QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=ED732D6F8E2B55D44E4470C64FCAE073;jsessionid=214BF0620B0A2FE13B9D3F5E32F144F5;jsessionid=7085ACC4AAD8C8D99A30DB27E7D2A4F1;jsessionid=80B08F65DE262B6F52E56B4216D09635;jsessionid=6999E2986F2F9AD8AACE0D0510147A6E;jsessionid=C9CBFDA03B134CF59E9BF79FAEE1EAC6;jsessionid=6B1ED88C6B4EAF9E85380DDEC4313AA9 (gene)

No studies found

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=ED732D6F8E2B55D44E4470C64FCAE073;jsessionid=214BF0620B0A2FE13B9D3F5E32F144F5;jsessionid=7085ACC4AAD8C8D99A30DB27E7D2A4F1;jsessionid=80B08F65DE262B6F52E56B4216D09635;jsessionid=6999E2986F2F9AD8AACE0D0510147A6E;jsessionid=C9CBFDA03B134CF59E9BF79FAEE1EAC6;jsessionid=6B1ED88C6B4EAF9E85380DDEC4313AA9